5 Things To Know: January 9, 2026

Summary

Andrew Ross Sorkin's January 9, 2026 pre-market '5 Things To Know' covers deal and capital-markets headlines rather than explicit trading recommendations. Items include reported Merck talks to buy RevMed, Strava's confidential IPO filing, a Saks owner bankruptcy financing report, and Paramount Skydance's MTV stake talks. The transcript ends during a NASA medical-condition item.

• Andrew Ross Sorkin reports five pre-market items for January 9, 2026.
• Merck is reportedly in talks to buy RevMed for $28-$32 billion.
• AbbVie denied a separate RevMed takeover report.
• Strava has confidentially filed for an IPO.
• The owner of Saks is nearing a $1 billion-plus bankruptcy financing package.
• Paramount Skydance is discussing taking a stake in MTV.
• The transcript ends as a NASA medical-condition item begins.